Aaron M. Allen, Robert I. Haddad, Roy B. Tishler Retropharyngeal Nodes in Hypopharynx Cancer on Positron Emission Tomography Journal of Clinical Oncology, 2007;25(5)—599-601. (2001)

Tishler, RB, Posner, MR, NorrisCM, jr, et al Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.Int J Rad Onc Biol Ohys, 2006;65(4)—1036-44.

 Posner MR, Wirth LJ: Cetuximab and radiotherapy for head and neck cancer. N Engl J Med2006, 354:634-636

 Haddad RI, Posner MR, Busse PM, et al: Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach. Am J Clin Oncol, 2006 29:153-157

 Goguen LA, Posner MR, Norris CM, et al Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 2006 134:916-922

 Wirth LJ, Haddad RI, Lindeman NI, et al: Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 2005 23:6976-6981

 DL Mager, AD Haffajee, PM Devlin, CM Norris, MR Posner, JM Goodson The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects Journal of Translational Medicine Jul 7 2005 3:27

 Guadagnolo BA, Haddad RI, Posner MR, et al: Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol August 2005 28(4):371—378

 Sullivan C, Haddad R, Tishler R et al: Chemoradiation Induced Cell Loss in Human Submandibular Glands. Laryngoscope 2005 Jun 115(6):958—64

 Haddad R, Mahadevan A, Posner M, Sullivan C: Long Term Survival With Adjuvant Carboplatin, Paclitaxel and Radiation Therapy in Anaplastic Thyroid Cancer. Am J Clin Oncol 2005 Feb; 28(1):104

 Gokhale A, Haddad R, Cavacini L et al: Serum Concentrations Of Interleukin-8, Vascular Endothelial Growth Factor, And Epidermal Growth Factor Receptor In Patients With Squamous Cell Cancer Of The Head And Neck. Oral Oncology 2005 41(1):70—76

 McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Lake-Willcutt B, Posner, MR, Van den Abbeele AD. Positron emission tomography with 18-F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head and Neck 2004 26:890—896

 Posner M, Haddad R, Wirth L et al: Induction Chemotherapy in Locally Advanced Squamous Cell Cancer of the Head and Neck: Evolution of the Sequential Treatment Approach. Seminars in Oncology 2004 Dec 31(6):778—785

 Sullivan C, Jaklitsch M, Haddad R et al: Endoscopic Management Of Hypopharyngeal Stenosis Following Organ Sparing Therapy For Head And Neck Cancer. Laryngoscope 2004 Nov 114(11):1924—1931

 McCollum AD, Burrell S, Haddad R, et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.Head and Neck 2004 Oct 26(10):890—896

 Haddad R, Weinstein L, Wieczorek T, Bhattarcharya N,  Raftopolous H, Oster M, Zhang X, Latham VM, Costello R, Faucher J, DeRosa C, Yule M, Miller LP, Loda M, Posner MR, Shapiro GL. A Phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent or refractory squamous cell carcinoma of the head and neck: Modulation of Retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor. Clinical Cancer Research 2004 10:4680—4687

 Devlin PM, Kazakian J,  Adak S, Li Y, Norris CM, Tishler, RB, Clark JR, Busse PM, Posner MR.  Prospective Phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck:  10 year follow-up.  American Journal of Clinical Oncology 2004 27:369—375

 Pignon JP, Syz N, Posner M, Olivares R,  Le Lann L, Yver A, Dunat A,   Lewin F, Dalley D, Pacagnella A, Taylor S, Domenge C,  Bourhis J, Mazumdar M. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck. Anti-Cancer Drugs 2004 15:331—340

 Marsit CJ, Liu M, Nelson HH, Posner M, Gazdar AF, Kelsey KT. Inactivation of the Fanconi Anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival. Oncogene 2004 23:1000—1004

 Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, Amrein P, Posner M. HER2 expression in salivary gland carcinomas: Dependence on histologic subtype. Clinical Cancer Research 2004 10:944—946

 Kotz T, Costello R, Li Y, Posner MR, Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck (SCCHN). Head and Neck 2004 26:365—372

 Wirth LJ, Haddad RI, Posner MR. Progress and perspectives in chemoprevention of head and neck cancer. Expert Review of Anticancer Therapy 2003 3:339—355

 Haddad RI, Colevas AD, Glisson B, Krane J, Cooper D, Amrein P, Costello R, Weeks L Posner MR. Herceptin in patients with advanced or metastatic salivary gland carcinomas. A Phase II study. Oral Oncology 2003 39:724—727

 Haddad RI, Wirth LJ, Posner MR.  The integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.  Expert Review of Anticancer Therapy 2003 3:339—355

 Haddad R, Posner MR. Palliative chemotherapy in patients with salivary gland neoplasms:  Review of the literature and preliminary reports of two recently performed phase II studies with single agents herceptin and gemcitabine.  Advances in Hematology & Oncology 2003 1:226—228

 Haddad RI, Tishler RB, Norris CM, Mahadevan A, Busse PM, Wirth L, Goguen LA, Sullivan CA, Costello R, Case M, Posner MR.  Docetaxel, cisplatinum, 5-Fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined modality treatment.  The Oncologist 2003 8:35—44

 Haddad R, Norris C, Tishler R, Busse P, Goguen L, Sullivan C, Norris C, Lake-Willcutt B, Case MA, Costello R, Posner M. Docetaxel, Cisplatin and 5-Fluorouracil Based Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Dana-Farber Cancer Institute Experience. Cancer 2003 Jan 15 97(2):412—418

 Haddad R, Norris C, Posner M.49 year old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy programs. Clinical Advances in Hematology & Oncology Jan 2003 1:58—61

 Haddad R, Posner M. RE: Phase II study of induction chemotherapy with paclitaxel, ifosfamide and carboplatin for patients with locally advanced SCC of the head and neck. Cancer 2003 March 15 97(6):1589

 Posner, MR, Lefebvre JL. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. British Journal of Cancer 2003 88:11-17

 Haddad R, Posner M: Palliative Chemotherapy in Patients With Salivary Gland Neoplasms: Review of The Literature and Preliminary Reports of Two Recently Performed Phase II Studies With Single Agents Herceptin And Gemcitabine. Clinical Advances in Hematology & Oncology April 2003 1:226—228

 Haddad R, Wirth L, Posner M: The Integration of Chemotherapy in the Curative Treatment of Locally Advanced Head and Neck Cancer. Expert Review of Anticancer Therapy 3(3):331—338

 Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT; Human Papillomavirus Type 16 and Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research  October 2002 8:3187—3192

 Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, Norris CM, Seroskie JD, Shin DM, Olivares R, Garay CA. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. Journal of Clinical Oncology 2001 19:1096—1104